Analysis of Japan's latest cancer 5-year survival rate data from the National Cancer Center. While prostate (94%) and thyroid (92%) show high survival rates, pancreatic cancer remains at only 10%. Examining the importance of early detection and 30-year survival trends.

World-first scientific proof that resistance training rejuvenates skin, revealed by Ritsumeikan University and POLA research. Discover how 16 weeks of strength training increases dermal thickness, improves skin elasticity, and reduces wrinkles through myokine secretion and inflammatory factor reduction.

SFTS, a tick-borne disease with 10-30% fatality rate. With treatment approved in 2024, early diagnosis is key. Japanese institutions including Osaka University are developing rapid diagnostic kits similar to flu tests. Record-high cases in 2025 with first Hokkaido infection raises nationwide concern.

Groundbreaking research from Shinshu University and Asahimatsu Foods reveals that koya-dofu (freeze-dried tofu), a traditional Japanese preserved food, contains resistant protein that promotes GLP-1 production, potentially preventing obesity and fatty liver disease. Discover why the world is turning to Japanese fermented and preserved foods for health benefits.

Japanese hospitals are facing an unprecedented financial crisis. Rising costs, staff shortages, and government policies are forcing healthcare facilities to close across the nation. Discover the factors behind this growing crisis and how it may reshape Japan's renowned healthcare system.

Researchers at Japan's JAIST discovered that Ewingella americana bacteria from Japanese tree frog intestines completely eliminated colorectal cancer in mice with a single dose, achieving 100% complete response rate. This breakthrough significantly outperformed existing chemotherapy and immunotherapy treatments.

A groundbreaking UK-Japan study reveals that playing Nintendo's Super Mario Bros. and Yoshi games can boost happiness and reduce burnout risk in young adults. Discover how the "childlike wonder" evoked by colorful visuals and cheerful music creates a mental reset that combats modern stress and exhaustion.

Kagoshima University's oncolytic virus "Surv.m-CRA-1" enters final clinical trials for primary malignant bone tumors. This revolutionary treatment can eliminate cancer stem cells resistant to conventional therapies, offering new hope for bone cancer patients who haven't seen a new drug in over 30 years. Learn about Japan's next-generation cancer therapy targeting 2027 approval.